22 April 2024
RNS non-regulatory
Investor Webinar 7 May 2024
Norcros plc ("Norcros" or the "Group"), a market-leading designer and supplier of high quality bathroom and kitchen products in the UK, Europe and South Africa markets, today announces that there will be an online investor webinar on Tuesday 7 May 2024.
The online webinar will take place at 11.00am and be hosted by Thomas Willcocks (CEO) and James Eyre (CFO). The presentation will cover the recent update on FY24 trading and highlight the key messages from the Capital Markets Event on 1 May regarding the Group's strategic priorities of Portfolio Development, Organic Growth, Operational Excellence and ESG.
The webinar is open to all existing and potential shareholders and registration for the event is free. Questions can be submitted in advance to info@equitydevelopment.co.uk and there will also be the opportunity to ask questions on the day.
To attend the event please register here
A recording will be available shortly after the webinar on www.equitydevelopment.co.uk
Enquiries
| Norcros plc | Tel: 01625 547700 |
| Thomas Willcocks, Chief Executive Officer | |
| James Eyre, Chief Financial Officer | |
| | |
| Equity Development Limited | Tel: 0207 065 2690 |
| Matt Evans
| |
| | |
| | |
Notes to Editors
Norcros is a market-leading designer and supplier of high quality bathroom and kitchen products in the UK, Europe and South African markets.
In the UK, Norcros operates under seven brands, Triton, Merlyn, Grant Westfield, Vado, Croydex, Abode, and Johnson Tiles.
In South Africa, Norcros operates under four brands, Tile Africa, House of Plumbing, TAL, and Johnson Tiles.
Norcros is headquartered in Wilmslow, Cheshire and employs around 2,300 people. The Company is listed on the London Stock Exchange. For further information please visit the Company website: http://www.norcros.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
